SynRx Therapeutics
PrivateLast Round
Series A
Dec 8, 2025
Total Funding Raised
$28.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SynRx Therapeutics operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series A round in December 2025.
SynRx Therapeutics is a biotechnology company that develops innovative oncology therapeutics focused on DNA damage repair pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynRx Therapeutics Comparables
Compare SynRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOMA Therapeutics | 88% | |
| Breakpoint Therapeutics | 86% | |
| Recombination Therapeutics | 86% |
For institutional investors. Book with your work email.
SynRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 8, 2025 | ||||
| Pre Seed | Nov 16, 2022 |
For institutional investors. Book with your work email.
SynRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Series A, Pre Seed |
| 杭州市人才集团有限公司 | Series A |
| Zhejiang Financial Holding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
$14.1M round led by Zhejiang Financial Holding.
- Nov 16, 2022
$14.2M round led by Lapam Capital.
For institutional investors. Book with your work email.
SynRx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SynRx Therapeutics's valuation, stock price, and market status.
Is SynRx Therapeutics a public or private company?
SynRx Therapeutics is a private company.
What is the current stock price of SynRx Therapeutics?
SynRx Therapeutics is a private company, so its shares have no public market price. Caplight tracks SynRx Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SynRx Therapeutics worth (valuation)?
Valuation information for SynRx Therapeutics is not publicly available.
Can I buy SynRx Therapeutics stock?
SynRx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SynRx Therapeutics's last funding round?
SynRx Therapeutics's most recent funding round was Series A on December 8, 2025.
Who are the main investors in SynRx Therapeutics?
Key investors in SynRx Therapeutics include Zhejiang Financial Holding.
Will SynRx Therapeutics IPO soon?
No public IPO plans have been announced for SynRx Therapeutics.
How can I track SynRx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SynRx Therapeutics's shares on secondary markets.